The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for...
Transcript of The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for...
![Page 1: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/1.jpg)
The Costs and Benefits of
Cannabis:
Social, Medical, and Public
Health Considerations
CADTH Symposium
Concurrent Session D3
May 16, 2019
Edmonton, AB
![Page 2: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/2.jpg)
Welcome!
![Page 3: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/3.jpg)
CADTH Housekeeping
Presentations will be made available on the CADTH web site the
day after the session.
An evaluation survey will be sent out after the symposium and
feedback on this session and the whole event will be greatly
appreciated.
Everyone who fills in a survey is helping raise money for the Pilgrims
Hospice Society in Edmonton, under the HTA Gives Back initiative.
Networking break will take place in the Exhibit and Poster area
(Pedway Level, Hall D and Hall D Foyer).
![Page 4: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/4.jpg)
Setting the Stage
Various medical cannabis access schemes (ACMPR) – since
2001
Cannabis Act 2018
Important to start talking about what it will take to allow
us to integrate cannabis into our health systems, as a tool
in managing a range of conditions
![Page 5: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/5.jpg)
Objective
To present a summary of the evolving evidence
for cannabis in managing key public health
challenges, particularly as it relates to cannabis
as a substitute for prescription and illicit opioids
and other prescription medicines.
![Page 6: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/6.jpg)
Speaker Introductions
Dr. Mark Ware - Canopy Growth Corporation
Dr. M-J Milloy - British Columbia Centre on Substance Use, UBC
Dr. Brian Emerson - BC Ministry of Health
Dr. Judith Glennie - Moderator
![Page 7: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/7.jpg)
![Page 8: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/8.jpg)
Medical Cannabis in Canada Dr. Mark A. Ware
Chief Medical Officer, Canopy Growth Corporation
Associate Professor of Medicine, McGill University
8
![Page 9: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/9.jpg)
Disclosure
I have the following relevant financial relationships to disclose:
• Employed by Canopy Growth Corporation (salary and stock options)
I have the following relevant non-financial relationships to disclose:
• Advised Canadian government on cannabis legalization and regulation 2000-2016
• Executive Director of non-profit Canadian Consortium for the Investigation of Cannabinoids (2007-2018)
![Page 10: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/10.jpg)
• Background on cannabis
– medical/recreational cannabis
– cannabis law
– emerging evidence
– current and future research (including RCTs)
• Implications of cannabis legalization for patient care
Objectives
![Page 11: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/11.jpg)
Dr Mark A. Ware McGill University 2017
![Page 12: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/12.jpg)
© Canadian Consortium for the Investigation of Cannabinoids
![Page 13: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/13.jpg)
Oh, Canada…
• Cannabis production
• 145 licensed producers
• 18,000 MDs
• >350,000 patients
• Increasing 10% per month
• Cannabis consumption
• Average amount authorized = 2.1g/day
• Average amount purchased = 0.75g/day
0
2000
4000
6000
8000
10000
12000
14000
Q1 2016 Q2 2016 Q3 2016 Q4 2016 Q1 2017 Q2 2017 Q3 2017 Q4 2017 Q1 2018 Q2 2018
Cannabis sales to patients 2016-18 (kgs)
Flower Oil
![Page 14: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/14.jpg)
![Page 15: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/15.jpg)
Dr Mark A. Ware McGill University 2017
• There is reasonable evidence that cannabinoids improve nausea and vomiting after chemotherapy. They might improve spasticity (primarily in multiple sclerosis).
• There is some uncertainty about whether cannabinoids improve pain, but if they do, it is neuropathic pain and the benefit is likely small.
• Adverse effects are very common, meaning that benefits would need to be considerable to warrant trials of therapy
![Page 16: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/16.jpg)
• Low methodological quality studies • Small trials (n<50); usually positive • Short trials limit long term efficacy assessment • Heterogeneity of “chronic pain” • “Lumping” together all cannabinoids/cannabis based medicines • Publication bias (unpublished negative trials) • Safety assessments poor
![Page 17: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/17.jpg)
• Case reports (e.g. edible overdose)
• Case series (e.g. cannabinoid-induced hyperemesis)
• Clinical trials (phase I-III)
• Post marketing surveillance (phase IV)
• “Real world” observational studies (e.g. COMPASS)
• Epidemiological studies (psychosis, driving, depression)
Cannabis safety
![Page 18: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/18.jpg)
-5.6%
-8.5%
-23.0% -24.8%
-30%
-25%
-20%
-15%
-10%
-5%
0%
Opioid prescriptions(Medicare)
Opioid doses (Medicaid)
Opioid-relatedhospitalizations
Opioid overdosemortality1 4 3 2
States with medical cannabis laws have reductions in:
1. Bradford AC et al. JAMA Intern Med 2018;178(5):667-72;
2. Wen H, Hockenberry JM. JAMA Intern Med 2018;178(5):673-79;
3. Shi Y. Drug Alcohol Depend 2017;173:144-50;
4. Bachhuber MA et al. JAMA Intern Med 2014;174(10):1668-73.
![Page 19: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/19.jpg)
![Page 20: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/20.jpg)
![Page 21: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/21.jpg)
![Page 22: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/22.jpg)
M-J Milloy, PhD Research scientist, British Columbia Centre on Substance Use
Canopy Growth Professor of Cannabis Science,
Assistant Professor, Department of Medicine, UBC
CANNABIS FOR HARM REDUCTION:
INVESTIGATING THE USE OF CANNABIS TO
ADDRESS THE NATIONAL OPIOID CRISIS
![Page 23: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/23.jpg)
DISCLOSURE
• I have no conflicts of interest to declare
• I have no personal financial relationships to the cannabis industry
• I am supported by:
– United States National Institutes of Health (U01-DA0251525);
– New Investigator award from the Canadian Institutes of Health Research;
– Scholar Award from the Michael Smith Foundation for Health Research;
• The University of British Columbia (UBC) has received an unstructured gift from
NG Biomed, Ltd., to support me;
• The Canopy Growth Professorship in Cannabis Science was established through
arms’ length gifts to UBC from Canopy Growth and the Government of British
Columbia’s Ministry of Mental Heath and Addictions
23
![Page 24: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/24.jpg)
24
I respectfully acknowledge the land on which I live and
work is the unceded traditional territory of the Coast
Salish Peoples, including the traditional territories of
xʷməθkwəy̓əm (Musqueam), Sḵwx̱wú7mesh
(Squamish), and Səl̓ílwətaɬ (Tsleil-Waututh) Nations.
![Page 25: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/25.jpg)
25
Source: Government of Canada,
www.canada.ca/en/health-canada/services/substance-use/problematic-prescription-drug-use/opioids/
![Page 26: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/26.jpg)
OPIOID OVERDOSE CRISIS
• Unprecedented numbers of opioid-related deaths across
United States and Canada
• Contributing factors include:
– Over-prescription of opioid analgesics;
– Contamination of illicit opioid supply with fentanyl;
– Public security-based approaches to illicit drug use
26
![Page 27: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/27.jpg)
OPIOID OVERDOSE CRISIS
• Low coverage of evidence-based approaches to opioid
use disorder & OD
– Opioid agonist therapies (e.g., methadone,
naloxone/buprenorphine, injectable diacetylmorphine)
– Peer-delivered naloxone
– Supervised consumption facilities
• Urgent need for new approaches to lower risk of
overdose
27
![Page 28: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/28.jpg)
28
![Page 29: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/29.jpg)
Table 1. Association between medical cannabis laws and state-level opioid
analgesic mortality rates in the United States, 1990–2010
29
![Page 30: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/30.jpg)
• Ecological evidence from United States suggests a
beneficial link between cannabis and opioid overdose
• Need for individual-level analyses on relationship
between cannabis use and overdose risk
30
![Page 31: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/31.jpg)
BCCSU Cohort Studies
– Three harmonized and complementary prospective cohort studies of > 3,500 people who use drugs (PWUD) in Vancouver
• Vancouver Injection Drug User Study (VIDUS): 1,500 HIV- people who
inject drugs (1996-);
• At-Risk Youth Study (ARYS): 1,000 street-involved youth who use drugs (2005-);
• AIDS Care Cohort to evaluate Exposure to Survival Services (ACCESS): 1,100 HIV+ PWUD (2005-)
31
![Page 32: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/32.jpg)
BCCSU Cohort Studies
– Individuals recruited from community settings in Downtown Eastside and Downtown South
– Biannual interviewer-administered questionnaire and nurse-led examination (HIV [ab, CD4, VL, geno], HCV [ab], UDS)
– Elicit data on sociodemographics, drug use, health care access, risk behaviours, etc.
– > 3,500 individuals & > 20,000 longitudinal interviews (1996–)
32
![Page 33: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/33.jpg)
RESULTS
• Cannabis use prevalent among people at risk of OD
– 56% used at least once in last six months;
– Among people who used cannabis in last six months, 40%
smoked cannabis at least daily
33
![Page 34: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/34.jpg)
34
Intention Any use L6M Most important use
L6M
To relieve pain 32% 17%
To help with sleep 34% 10%
To help with HIV medications/AIDS symptoms 2% 1%
To treat nausea/lack of appetite 24% 8%
To substitute for other substances 12% 4%
To relieve stress 37% 16%
To treat a mental health concern (other than addiction) 15% 7%
To get high or socialize 45% 34%
Table 1: Self-reported reasons for recent cannabis use among 1425
people who use illicit drugs in Vancouver, Canada
![Page 35: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/35.jpg)
35
![Page 36: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/36.jpg)
Among 810 individuals initiating opioid
agonist therapy, ≥ daily cannabis use was
associated with a 21% greater likelihood
of being retained in treatment six months
later during 9,284 person-years of
observation (Adjusted Odds Ratio = 1.21,
95% CI: 1.04–1.41)
36
![Page 37: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/37.jpg)
37
![Page 38: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/38.jpg)
38
Among 669 people who use illicit drugs during a
community-wide overdose crisis, having a positive
urine drug screen for fentanyl was negatively
associated with a positive urine drug screen for
THC (AOR = 0.52, 95% CI: 0.31–0.83)
![Page 39: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/39.jpg)
WORKS IN PROGRESS
• Among 2,619 active people who inject drugs, frequent cannabis use was significantly and longitudinally associated with decreased frequency of injection drug use (AOR = 0.81, 95% CI: 0.73–0.89)
• Among 1,160 people who use illicit drugs with chronic pain, frequent cannabis use was significantly and longitudinally associated with lower odds of daily illicit opioid use (AOR = 0.46, 95% CI: 0.31–0.69)
39
![Page 40: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/40.jpg)
40
![Page 41: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/41.jpg)
LIMITATIONS
• BCCSU cohorts not randomly recruited;
representativeness to other groups of people who use
drugs unknown;
• Some drug use data self-reported;
• Time of detection for urine drug screens differ by
metabolite;
• Retrospective data on cannabis use does not include
details of cannabis type, route of administration, dose,
etc.
41
![Page 42: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/42.jpg)
DISCUSSION
• Cannabis use common among people at risk of opioid
overdose
• >75% report therapeutic use of cannabis (pain, nausea,
sleep, substitution)
• Cannabis use associated with:
– 34% lower odds of non-fatal overdose;
– 21% greater odds of retention in treatment of opioid use
disorder;
– 48% lower odds of exposure to fentanyl
42
![Page 43: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/43.jpg)
CANNABIS TO MITIGATE OPIOID CRISIS
Findings support need for experimental trials among
humans
– Are cannabinoid-based interventions effective at reducing risk
of drug-related harms during a community-wide overdose
crisis?
![Page 44: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/44.jpg)
M-J Milloy, PhD
Research scientist, BC Centre on Substance Use;
Canopy Growth Professor of Cannabis Science,
Assistant Professor, Department of Medicine, UBC
![Page 45: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/45.jpg)
![Page 46: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/46.jpg)
46
Best Brains Exchange: The Benefits, Risks and Costs of Cannabis
for Therapeutic Purposes
2019 CADTH Symposium, Edmonton
Dr. Brian Emerson, A/Deputy Provincial Health Officer
BC Ministry of Health
April 16th, 2019
![Page 47: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/47.jpg)
Disclosure
I have no financial relationships with cannabis or
pharmaceutical commercial interests
Employee Vancouver Island Health Authority/BC
Ministry of Health
No actual or potential conflicts of interest
47
![Page 48: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/48.jpg)
Best Brains Exchange
June 15, 2018 in Victoria, BC at
the Ministry of Health
Collaborators:
Canadian Institutes of Health
Research
Michael Smith Foundation for
Health Research
BC Centre on Substance Use
48
![Page 49: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/49.jpg)
Objectives
Bring together stakeholders to explore what information and
research is needed to develop policies for the therapeutic use of
cannabis in BC
evidence and gaps on benefits, risks, costs and professional training
requirements;
how other jurisdictions have addressed;
ways of acquiring/generating evidence to assist in determining whether
cannabis should be covered as a publicly insured benefit.
49
![Page 50: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/50.jpg)
Key Themes
Pan-Canadian research strategy needed
Legalization makes cannabis research timely
Need for coordination and consistency of approach in cannabis
research
Canada has opportunity to lead in open science
Important to bring multiple stakeholders to the table
50
![Page 51: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/51.jpg)
Key Themes cont’d
Opportunity to study the intersection between cannabis, pain and
opioids
Respect for Indigenous people and Canada’s many cultures
Cannabis “not a good fit” for current clinical trial and regulatory
pathway used for pharmaceuticals
Opportunity to look at current insurance coverage for medical
cannabis to research cannabis use and coverage in parallel
51
![Page 52: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/52.jpg)
What Evidence is Needed?
Data on cost-effectiveness, including comparisons to other drugs
and impact on quality of life;
Clinical trials looking at prime areas of current use, including pain
control, nausea, spasticity and sleep assistance; and,
Attention to the current barriers, including the difficulties in the
regulation of medical cannabis.
52
![Page 53: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/53.jpg)
How can Evidence be Gathered Efficiently?
Focus on issues where there is already evidence for the efficacy of
cannabis (e.g., pain control to alleviate use of opioids);
Clinical trials; and,
Bring multiple stakeholders together to put studies and funding
together (including regulators, medical associations, societies that
represent patient needs, licensed providers, and government
research funders).
53
![Page 54: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/54.jpg)
Capitalize on Natural Experiments
Look at use and outcomes data
Learn from the current practices of insurance companies
Learn from patient advocacy work that has already been done
Create academic partnerships to include data sharing
Link medical cannabis use to administrative data
54
![Page 55: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/55.jpg)
Next Steps & Recent Developments
BC Research Network established
CIHR Integrated Cannabis Research Strategy
Research registries to promote coordination (CCSA, CCIC)
Question on insurance coverage for medical cannabis to be included
in Canadian Cannabis Survey (data collection in spring 2019)
55
![Page 56: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/56.jpg)
Next Steps & Recent Developments Interim report from the Advisory Council on the Implementation of National
Pharmacare (Eric Hoskins, Chair)
Recommends developing a national formulary – should cannabis be included?
Towards open science: Promoting innovation in pharmaceutical research and
development and access to affordable medications both in Canada and abroad
(Standing Committee on Health)
Canadian Pain Task Force - provide advice to Health Canada regarding prevention
and management of chronic pain.
56
![Page 58: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/58.jpg)
Audience Q&A Please state your name and organization prior to sharing your question.
![Page 59: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/59.jpg)
CADTH Housekeeping
Presentations will be made available on the CADTH web site the
day after the session.
An evaluation survey will be sent out after the symposium and
feedback on this session and the whole event will be greatly
appreciated.
Everyone who fills in a survey is helping raise money for the Pilgrims
Hospice Society in Edmonton, under the HTA Gives Back initiative.
Networking break will take place in the Exhibit and Poster area
(Pedway Level, Hall D and Hall D Foyer).
![Page 60: The Costs and Benefits of Cannabis: Social, …...The Benefits, Risks and Costs of Cannabis for Therapeutic Purposes 2019 CADTH Symposium, Edmonton Dr. Brian Emerson, A/Deputy Provincial](https://reader034.fdocuments.in/reader034/viewer/2022050206/5f59032a8c1cb13c2c5faad2/html5/thumbnails/60.jpg)
Thank you!